Latest California Healthline Stories
For Low-Income Drug Users, Medi-Cal Offers A Fresh Start
Under a five-year agreement with the federal government, California is using Medicaid dollars to expand drug treatment, including more inpatient care and a broader range of medications.
New Commission Plans To Address State Health Care Worker Shortage
Kaiser Health News senior correspondent Anna Gorman discussed the shortage Thursday with KPCC’s Libby Denkman, on the radio station’s Take Two program.
Nueva droga contra la leucemia ofrece esperanza, pero a un costo millonario
El tratamiento con una nueva droga del laboratorio Novartis para casos en los que ha fracasado la quimioterapia o el trasplante de médula costaría $649,000.
To Ensure The Doctor Is Always In, New Panel Tackles Health Worker Shortage
The California Future Health Workforce Commission will produce recommendations intended to meet the demand for medical professionals in a state with a growing and increasingly diverse population.
‘Breakthrough’ Leukemia Drug Also Portends ‘Quantum Leap’ In Cost
A genetically altered cancer drug, based on CAR T-cell therapies, could be a big success with leukemia patients but at a staggering cost.
Las voces olvidadas en el debate de salud: 8 mujeres cuentan sus historias
Los proyectos de salud que se han estado discutiendo dejan de lado muchos de los servicios esenciales para las mujeres, como el cuidado materno y los métodos anticonceptivos.
Often Missing In The Health Care Debate: Women’s Voices
When leaders in Washington discuss the future of American health care, women are not always in the room. Here, nine women share their personal stories, fears and hopes.
Más médicos apoyan un sistema de salud universal
Una nueva encuesta revela que cada vez más los profesionales de la salud se inclinan a un sistema con un pagador único que se haga cargo de las cuentas médicas.
Doctors Warm To Single-Payer Health Care
Growing numbers of physicians say they support a single-payer health care system, a 180-degree turn in opinion over a decade.
Hospitals Slashed Use Of Two Heart Drugs After Huge Price Hikes
Hospital use of two popular heart medicines, nitroprusside and isoproterenol, dramatically dropped after the prices for both soared.